Recently Viewed
Clear AllQuality Score
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹1,502 Cr
P/E Ratio
31.27
P/B Ratio
5.78
Industry P/E
35.82
Debt to Equity
0
ROE
15.42 %
ROCE
21.21 %
Div. Yield
0.17 %
Book Value
303.11
EPS
55.98
CFO
₹196.48 Cr
EBITDA
₹276.56 Cr
Net Profit
₹222.16 Cr
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
---|---|---|---|---|---|---|---|
3B Blackbio Dx
| -11.53 | 4.71 | 3.03 | 119.24 | 68.67 | 66.56 | 69.39 |
BSE Commodities
| 2.79 | 0.64 | 7.28 | 2.70 | 8.31 | 29.08 | -- |
BSE Small Cap
| -12.04 | 2.97 | -0.32 | 2.02 | 18.80 | 34.92 | 16.25 |
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
---|---|---|---|---|---|---|---|
3B Blackbio Dx
| 144.72 | 69.54 | 4.44 | 25.15 | 292.88 | -0.28 | -19.49 |
BSE Small Cap
| 29.04 | 47.52 | -1.80 | 62.77 | 32.11 | -6.85 | -23.41 |
BSE Commodities
| 8.14 | 17.51 | 1.22 | 61.53 | 26.07 | -4.62 | -19.21 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
---|---|---|---|---|
9,556.00 | 3,982.89 | 21.78 | 17.82 | |
1,309.50 | 5,974.86 | 21.3 | 22.19 | |
235.19 | 4,569.05 | 36.55 | 6.49 | |
553.90 | 5,007.24 | 20.5 | 10.78 |
No Review & Analysis are available.
Kilpest India Limited, an agriculture based company, manufactures and sells pesticides and other agrochemical products in India. Its chemical products include insecticides, anti-bacterial, fungicides, herbicides/weedicides, and public health... products; and biological products comprise bio pesticides, bio fungicides, bio fertilizers, bio nematicides, and health and hygiene related products, as well as micro fertilizers and plant growth stimulants. The company also exports its products to Bangladesh and Afghanistan. In addition, it offers a range of diagnostic kits for various diseases ranging from infectious diseases to oncology. The company was founded in 1972 and is based in Bhopal, India. Read more
Incorporated
1972
Chairman
Dhirendra Dubey
Managing Director
Dhirendra Dubey
Headquarters
Bhopal, Madhya Pradesh
Website
The total asset value of 3B BlackBio Dx Ltd stood at ₹ 269 Cr as on 31-Dec-24
The share price of 3B BlackBio Dx Ltd is ₹1,750.60 (BSE) as of 28-Apr-2025 IST. 3B BlackBio Dx Ltd has given a return of 68.67% in the last 3 years.
3B BlackBio Dx Ltd has a market capitalisation of ₹ 1,502 Cr as on 28-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of 3B BlackBio Dx Ltd is 5.78 times as on 28-Apr-2025, a 28% premium to its peers’ median range of 4.51 times.
The P/E ratio of 3B BlackBio Dx Ltd is 31.27 times as on 28-Apr-2025, a 13% discount to its peers’ median range of 35.82 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the 3B BlackBio Dx Ltd and enter the required number of quantities and click on buy to purchase the shares of 3B BlackBio Dx Ltd.
Kilpest India Limited, an agriculture based company, manufactures and sells pesticides and other agrochemical products in India. Its chemical products include insecticides, anti-bacterial, fungicides, herbicides/weedicides, and public health products; and biological products comprise bio pesticides, bio fungicides, bio fertilizers, bio nematicides, and health and hygiene related products, as well as micro fertilizers and plant growth stimulants. The company also exports its products to Bangladesh and Afghanistan. In addition, it offers a range of diagnostic kits for various diseases ranging from infectious diseases to oncology. The company was founded in 1972 and is based in Bhopal, India.
The prominent promoters of 3B BlackBio Dx Ltd are
Name of promoters | Holding percentage |
---|---|
MITHLA DUBEY |
12.35%
|
MITHALA LABORATORIES PRIVATE LIMITED |
9.56%
|
DHIRENDRA DUBEY |
8.44%
|
The chairman of the company is Dhirendra Dubey, and the managing director is Dhirendra Dubey.
There is no promoter pledging in 3B BlackBio Dx Ltd.
Some of the close peers are:
Company | Market Cap(₹ Cr) |
---|---|
5,980
|
|
4,955
|
|
4,629
|
|
4,093
|
3B BlackBio Dx Ltd | Ratios |
---|---|
Return on equity(%)
|
20.46
|
Operating margin(%)
|
52.55
|
Net Margin(%)
|
43.52
|
Dividend yield(%)
|
0.17
|
Yes, TTM profit after tax of 3B BlackBio Dx Ltd was ₹48 Cr.